Short Interest in OKYO Pharma Limited (NASDAQ:OKYO) Increases By 21.7%

OKYO Pharma Limited (NASDAQ:OKYO) was the target of a large increase in short interest during the month of July. As of July 15th, there was short interest totalling 48,300 shares, an increase of 21.7% from the June 30th total of 39,700 shares. Approximately 0.2% of the company’s stock are sold short. Based on an average daily volume of 22,000 shares, the short-interest ratio is currently 2.2 days.

Analysts Set New Price Targets

Separately, HC Wainwright reaffirmed a “buy” rating and set a $7.00 price objective on shares of OKYO Pharma in a research report on Thursday, July 11th.

OKYO Pharma Price Performance

Shares of OKYO Pharma stock traded up $0.01 during trading on Friday, hitting $1.36. 28,651 shares of the stock were exchanged, compared to its average volume of 32,025. The firm’s 50-day moving average price is $1.37 and its 200 day moving average price is $1.44. OKYO Pharma has a 12-month low of $1.09 and a 12-month high of $3.07.

About OKYO Pharma

OKYO Pharma Limited, a clinical-stage biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead preclinical product candidate is OK-101, which is in Phase II clinical trials for the treatment of dry eye disease.